Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home
Login

International Journal of Medical Sciences And Clinical Research

Peer Reviewed | Open Access | E-ISSN: 2771-2265
Published Article

Cardiohemodynamic Disorders and The Efficiency of Combination Therapy for COPD Associated with Pulmonary and Arterial Hypertension

Cardiohemodynamic Disorders and The Efficiency of Combination Therapy for COPD Associated with Pulmonary and Arterial Hypertension

Authors

  • Shamukhamedova N.Sh.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Daminov B.T.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Kadirova G.G.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Abrorova B.T.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.37547/ijmscr/Volume06Issue04-13

Keywords:

Chronic obstructive pulmonary disease arterial hypertension pulmonary hypertension

Abstract

COPD is often associated with cardiovascular diseases, including pulmonary and arterial hypertension, which contributes to a worse prognosis and the progression of cardiorespiratory impairment. Pulmonary hypertension, associated with lung disease and hypoxia, is one of the most common forms of secondary pulmonary hypertension following left heart disease.

 

References

Agustí A, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report. Am J Respir Crit Care Med. 2023.

Barberà JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. European Respiratory Journal. 2003;21(5):892–905.

Gupta A, et al. Mortality trends in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2026.

Humbert M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022.

Karnati S, Seimetz M, Klepetko W, et al. Chronic obstructive pulmonary disease and the vascular system: vascular alterations and oxidative stress. Frontiers in Cardiovascular Medicine. 2021; 8:649512.

Klinger JR. Pulmonary hypertension due to COPD. Respir Med. 2023.

Wang X, et al. Global trends and future projections of COPD burden. 2025.

Wang Y, et al. Chronic obstructive pulmonary disease across three decades. Front Med. 2025.

World Health Organization. Chronic obstructive pulmonary disease (COPD) fact sheet. 2024.